Guideline 7
Cross-phase quality assurance
Researchers carry out each step of the research process lege artis. When research findings are made publicly available (in the narrower sense of publication, but also in a broader sense through other communication channels), the quality assurance mechanisms used are always explained. This applies especially when new methods are developed.
Explanations:
Continuous quality assurance during the research process includes, in particular, compliance with subject-specific standards and established methods, processes such as equipment calibration, the collection, processing and analysis of research data, the selection and use of research software, software development and programming, and the keeping of laboratory notebooks.
If researchers have made their findings publicly available and subsequently become aware of inconsistencies or errors in them, they make the necessary corrections. If the inconsistencies or errors constitute grounds for retracting a publication, the researchers will promptly request the publisher, infrastructure provider, etc. to correct or retract the publication and make a corresponding announcement. The same applies if researchers are made aware of such inconsistencies or errors by third parties.
The origin of the data, organisms, materials and software used in the research process is disclosed and the reuse of data is clearly indicated; original sources are cited. The nature and the scope of research data generated during the research process are described. Research data are handled in accordance with the requirements of the relevant subject area. The source code of publicly available software must be persistent, citable and documented. Depending on the particular subject area, it is an essential part of quality assurance that results or findings can be replicated or confirmed by other researchers (for example with the aid of a detailed description of materials and methods).
Comments - Life sciences (2)
Guidelines for quality-promoting aspects in medicine and biomedicine
06.07.2021 – An orientation for applicants, reviewers and committee members.
Comment on: Preamble (Life sciences) , Preamble (Statements) , GL7 (Life sciences) , GL7 (Statements) , GL9 (Life sciences) , GL9 (Statements) , GL11 (Life sciences) , GL11 (Statements) , GL12 (Life sciences) , GL12 (Statements)
Overarching quality assurance in the life sciences
03.12.2020 – In the life sciences, quality assurance in a research project begins with thorough research into the state of knowledge and a clear definition of where there are gaps in knowledge. Researchers are expected to use contemporary analytical methods for ...
Comment on: GL7 (Life sciences) , GL13 (Life sciences)